Product NDC: | 64455-993 |
Proprietary Name: | ZOVIRAX |
Non Proprietary Name: | acyclovir |
Active Ingredient(s): | 50 mg/g & nbsp; acyclovir |
Administration Route(s): | TOPICAL |
Dosage Form(s): | OINTMENT |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 64455-993 |
Labeler Name: | BTA PHARMACEUTICALS INC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA018604 |
Marketing Category: | NDA |
Start Marketing Date: | 20041029 |
Package NDC: | 64455-993-20 |
Package Description: | .9 g in 1 PACKET (64455-993-20) |
NDC Code | 64455-993-20 |
Proprietary Name | ZOVIRAX |
Package Description | .9 g in 1 PACKET (64455-993-20) |
Product NDC | 64455-993 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | acyclovir |
Dosage Form Name | OINTMENT |
Route Name | TOPICAL |
Start Marketing Date | 20041029 |
Marketing Category Name | NDA |
Labeler Name | BTA PHARMACEUTICALS INC |
Substance Name | ACYCLOVIR |
Strength Number | 50 |
Strength Unit | mg/g |
Pharmaceutical Classes | DNA Polymerase Inhibitors [MoA],Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient] |